Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to,,,Bypass Surgery and Better Outcomes Than Bare Metal Stents in,,,Subgroup Analysis of Diabetic Patients With Multivessel Coronary,,,Disease
ficantly lower than the rate in the bare metal stent arm of
the ARTS I Study (1.3 percent versus 7.1 percent, respectively; p =
0.018). Three-year stent thrombosis comparisons with the BMS arm
were not possible, as the ARTS I Study did not track stent
thrombosis rates beyond 30 days. The cumulative rates of definite
stent thrombosis for the CYPHER(R) Stent at three-year follow-up in
the overall ARTS II Study patient population was 3.3 percent.
Investigators did not find significant differences in the stent
thrombosis rates between the ARTS II diabetic and non-diabetic
patients using any of the ARC definitions.
The CYPHER(R) Stent does not have an approved indication in the
United States for diabetic patients or patients with multivessel
About the CYPHER(R) Stent
The CYPHER(R) Stent has been chosen by cardiologists worldwide
to treat approximately three million patients with coronary artery
disease. The safety and efficacy of the device is supported by a
robust clinical trial program that includes more than 70 studies
that examine the performance of the CYPHER(R) Stent in a broad
range of patients.
Developed and manufactured by Cordis Corporation, the CYPHER(R)
Stent is currently available in more than 80 countries and has the
broadest clinical experience and longest-term clinical follow-up of
any drug-eluting stent. The next version of sirolimus-eluting
stent, the CYPHER(R) SELECT(TM) Sirolimus- eluting Coronary Stent,
was launched in Europe, Asia Pacific, Latin America and Canada in
2003. The CYPHER(R) SELECT(TM) Plus Stent, the third version of a
sirolimus-eluting coronary stent, received CE Mark in 2006 and is
currently available in many markets outside the United States.
For more complete information on indications, contraindications,
warnings and precautions, see the Instructions for Use available at
Page: 1 2 3 4 Related medicine technology :1
. Cypher Sirolimus-eluting Coronary Stent Had Similar Results to
Bypass Surgery in Long-Term Study of Patients With Multi-Vessel
Coronary Artery Disease2
. Two-Year Patient Registry Results Support Safety and Efficacy of
Cypher Sirolimus-Eluting Coronary Stent in Real World Uses3
. New Study Suggests Better Patient Outcomes with CYPHER
Sirolimus-Eluting Coronary Stent than with Taxus Stent in
Real-World Clinical Settings4
. New Point-of-Care Methods to Measure Coronary and Cerebrovascular Risk5
. BusinessWeek Article Highlights Promising Breakthrough Treatment
for Advanced Coronary Artery Disease6
. BusinessWeek Article Highlights Promising Breakthrough Treatment
for Advanced Coronary Artery Disease7
. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by
Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who
Experienced a Recent Stroke8
. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery
Calcification, a Predictor of Cardiovascular Events, in Women aged
50-59 taking Estrogen Therapy9
. Positive Results for Second-Generation Taxus Liberte Coronary Stent
System Highlighted in Journal of American College of Cardiology10
. Abbott Announces Positive Nine-Month Results From the Worlds First
Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent11
. Abbott Announces Continued Positive Results with Xience V
Everolimus Eluting Coronary Stent in Spirit Clinical Trials
(Date:1/23/2015)... 23, 2015 A new analysis of Centers for Medicare ... data shows that 81 percent of seniors chose lower-cost ... discounts at certain pharmacies. The findings were released by ... are now the foundation of Medicare Part D," said ...
(Date:1/23/2015)... Fla. and DUBLIN , Jan. ... the agreement with KRS Global Biotechnology, Inc. for the compounding, ... be compounded for shipment in the United States ... FDA approved Outsourcing Facility capable of compounding naltrexone tablets in ...
(Date:1/23/2015)... , Jan. 23, 2015 Now available for sale, ... 7,849,611) support that prevents ankle sprains by cushioning the ... it fits securely around the outside of any shoe ... & comfort while still offering protection against sprains. With ... Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2
(Date:1/22/2015)... 22, 2015 For over 20 years, Dr. David ... and Vista area has treated just about every type of ... circumstances. And for those same twenty-plus years, the team at ... those injuries with the best possible doctor. With the ...
(Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... American College of Sports Medicine flagship journal Medicine ... supplementation with L-Citrulline before exercise may help reduce ... strenuous exercise. 1 , Participants in the ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 IsoComforter, Inc. has ... machine with patented IsoTube design to treat specific body parts ... the most progressive and easy to use patented cold therapy ... and sports related orthopedic and muscle injuries. IsoComforter has ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and the ... an effort to further promote visibility and adoption of the ... made AMA journals available via its subscription services, EBSCO will ... , Long known as both a subscription agency ...
(Date:1/22/2015)... Compare-autoinsurance.org has released a new blog post presenting a list of ... . , Some types of vehicles cannot be covered under ... blog post to see if their vehicle qualifies for auto insurance ... of the cars that cannot be covered by a plan. Clients ... Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
... , ... premiere brand for love and relationships, proudly announces the launch of ProConnect, a new ... professionals grow their businesses. , ... New York, NY (PRWEB) June 21, 2010 -- YourTango.com , the ...
... ... localized approach to design , ... Shoreview, Minn. (PRWEB) June 21, 2010 -- Ecumen’s new senior housing community in ... housing in America that features seed and livestock feed bags as window treatments and other ...
... ... are now hiring as a result of a substantial increase in business. , ... (PRWEB) June 21, 2010 -- VoiceWalker ... release of Digital Voice Advantage, their suite of Voice over IP (VOIP) products for small ...
... ... Surgeons., , ... June 21, 2010 -- LapBandDoctors.com is pleased to announce an open, professional membership available to ... only an information portal for those considering lap band surgery , but is also ...
... with higher blood levels of a common flame retardant ... have implications for fetal health, according to a new ... Berkeley. "This is the first study with ... PBDE flame retardants and thyroid function in pregnant women," ...
... tetanus shots, study finds , SUNDAY, June 20 (HealthDay ... biphenyls (PCBs) may have a reduced immune response to ... The findings suggest that exposure to the environmental pollutants ... in immune system development) could undermine the effectiveness of ...Cached Medicine News:Health News:YourTango's Innovative Marketing Platform Boosts Business For Relationship & Dating Professionals 2Health News:YourTango's Innovative Marketing Platform Boosts Business For Relationship & Dating Professionals 3Health News:YourTango's Innovative Marketing Platform Boosts Business For Relationship & Dating Professionals 4Health News:New Senior Housing in Minnesota by Ecumen Honors Agricultural Heritage 2Health News:Now Hiring: VoipWalker, Inc. DBA VoiceWalker, Experiences Significant Up-Tick in Business, Enters Hiring Mode 2Health News:LapBandDoctors.com Announces Open Membership To Lap Band Surgery Professionals Around The Country. 2Health News:Flame retardant linked to altered thyroid hormone levels during pregnancy 2Health News:Flame retardant linked to altered thyroid hormone levels during pregnancy 3Health News:PCBs May Weaken Kids' Vaccination Response 2
CMF OL1000 Bone Growth Stimulators are portable, battery-powered medical devices indicated for use in the noninvasive treatment of an established nonunion fracture acquired secondary to trauma, exclu...
... the surgical versatility you demand when treating ... EBI OsteoGen-D offers 40 microamperes of direct ... with 20 microamperes. Available in both Mesh ... flexibility with any of your bone graft ...
... area contact between grant material and fracture ... long bones., ,Grid-Like Format of Mesh Cathode ... Bone , ,The innovative Mesh Cathode of ... area and a scaffolding effect designed to ...
Flowmate makes portable uroflowmetry easy, accurate and dignified. Flowmate has automatic start and stop as well as simple and straightforward reporting from its own printer....Medicine Products: